The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Wilson Disease Neurologic Involvement

Movement disorders, dystonia, and psychiatric findings developing as a result of copper accumulation in the basal ganglia.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Wilson Disease Neurologic Involvement?

Wilson disease (WD, hepatolenticular degeneration) is an autosomal recessive copper metabolism disease developing as a result of mutations in the ATP7B gene (chromosome 13); copper accumulation occurs in the liver, brain, kidney, and cornea due to impaired copper-bile excretion; prevalence is 1/30,000-1/50,000.

Clinical presentations: hepatic form (40%, in 5-15 years - elevated transaminases, hepatitis, cirrhosis, fulminant liver failure), neurologic form (40-50%, in 15-30 years - movement disorders), psychiatric form (10%, depression, behavioral changes, psychosis), Coombs-negative hemolytic anemia, renal Fanconi syndrome.

Neurologic findings: dysarthria (most common, 80% - speech impairment, slurred speech, monotone), dystonia (60% - facial 'risus sardonicus', cervical, generalized), tremor (50% - 'wing-beating tremor' is characteristic), parkinsonism (50% - bradykinesia, rigidity, gait disturbance), ataxia, dysphagia, drooling, autonomic dysfunction. Cognitive: executive dysfunction, mild cognitive impairment, dementia (advanced). Diagnosis: serum ceruloplasmin <20 mg/dL, 24-hour urine copper >100 µg/day, Kayser-Fleischer ring (slit lamp - specific for neurologic form 95%), ATP7B genetic test, brain MRI ('panda face', 'face of giant panda' classic), liver biopsy (>250 µg/g dry weight). Treatment: chelating therapy (D-penicillamine, trientine), zinc, low-copper diet, liver transplantation.

Symptoms

Dysarthria (slurred-monotonous speech, 80% - most common)
Dystonia (facial 'risus sardonicus' grimace, cervical, generalized)
Tremor (resting, postural, intentional, 'wing-beating')
Parkinsonism (bradykinesia, rigidity, mask face)
Ataxia (gait disturbance, balance problem)
Dysphagia (swallowing difficulty), drooling
Cognitive findings: executive dysfunction, attention problem, dementia
Psychiatric findings: depression (in 40%), psychosis, behavioral change
Hepatic findings (often coexists): jaundice, ascites, hepatomegaly
Eye findings: Kayser-Fleischer ring, sunflower cataract
Sleep disorders, micrography
School-work failure (in adolescents)

Risk Factors

Family history (autosomal recessive transmission, parents heterozygous)
Sibling Wilson disease
Pre-15 years hepatic findings + 15-30 years neurologic findings
Genetic mutations: ATP7B (>800 mutations identified)
Consanguineous marriage
Founder effect (Mediterranean, Eastern European population)
Asymptomatic homozygote (50% of family members)
High copper intake (occupational, water source)
Pregnancy (female form deterioration)
Hepatotoxic drugs (worsening)

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • New onset dysarthria, drooling in young (15-30) patient
  • Bilateral fine tremor, especially with walking
  • Persistent unexplained behavioral change in adolescent
  • Familial Wilson disease + new onset symptoms
  • Liver dysfunction + tremor
  • Persistent severe depression in young (drug ineffective)
  • Sudden academic decline + tremor in young patient
  • Coombs-negative hemolytic anemia + liver dysfunction
  • Sister-brother Wilson diagnosis + asymptomatic (screening)

Treatment Methods

01
Serum ceruloplasmin (<20 mg/dL diagnostic clue)
02
24-hour urine copper (>100 µg/day diagnostic)
03
Slit lamp examination (Kayser-Fleischer ring)
04
Brain MRI (basal ganglia hyperintensity, 'panda face' midbrain)
05
Liver biopsy + copper measurement (>250 µg/g dry weight)
06
ATP7B genetic test (definitive diagnosis)
07
Family screening (siblings asymptomatic 50% homozygote)
08
Chelating therapy (first-line):
09
- D-penicillamine 750-1500 mg/day (cheap, side effects: rash, proteinuria, BM suppression)
10
- Trientine 1000-1500 mg/day (D-pen intolerance, less side effects)
11
- Pretreatment 'paradoxical neurologic deterioration' risk (10-50%) - slow titration
12
Zinc (zinc acetate 50 mg 3×/day) - maintenance treatment, asymptomatic
13
Low-copper diet: avoid liver, shellfish, mushroom, nuts, chocolate
14
Symptomatic treatment:
15
- Tremor: trihexyphenidyl, propranolol, primidone
16
- Dystonia: anticholinergic, baclofen, BoNT injection
17
- Parkinsonism: levodopa (often not very effective)
18
- Psychosis: atypical antipsychotic (avoid haloperidol)
19
Speech therapy, physiotherapy, occupational therapy
20
Liver transplantation: fulminant liver failure, advanced cirrhosis (definitive treatment)
21
Lifelong follow-up: 24-hour urine copper, liver enzymes, neurologic examination
22
Pregnancy planning: continue therapy, fetal surveillance
23
Genetic counseling, prenatal diagnosis

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.